Jun cheng | Public Health | Best Researcher Award

Prof. Jun cheng | Public Health | Best Researcher Award

director of dept. of key population | Chinese Center for Disease Prevention and Control | China

Dr. Jun Cheng is a prominent figure in tuberculosis (TB) prevention and control in China, currently serving as the Director of the Department of Key Population at the National Center for Tuberculosis Prevention and Control, Chinese Center for Disease Prevention and Control (China CDC). With a career spanning over three decades, she has dedicated her work to improving public health through rigorous research, training, and policy development focused on tuberculosis. Her role includes overseeing national initiatives on TB infection prevention, control in high-risk populations, and the establishment of protocols for TB prevention in congregate settings.

Profile

Orcid

Education:

Dr. Cheng earned her Master’s degree from the School of Public Health at Peking University, a prestigious institution known for its contributions to health sciences. Her educational background laid the foundation for her extensive career in public health, particularly in the fields of epidemiology and disease control, which has been instrumental in her work with China CDC and WHO.

Experience:

Dr. Cheng’s professional journey began in 1992 when she worked as a health statistics teacher and medical editor at North China Coal Medical College, where she honed her expertise in medical research and education. From 2004 to 2009, she worked as a professional researcher at the Beijing Institute of Cardiovascular and Pulmonary Diseases, focusing on epidemiological surveys and cardiovascular disease research. Since 2009, Dr. Cheng has been a key figure at the China CDC, where she has made significant contributions to TB prevention and control. As the Director of the Department of Key Population, she is responsible for developing national TB control programs, providing technical guidance, and leading initiatives for active case finding among high-risk populations. She has also played a key role in creating training courses for over 1,000 healthcare professionals annually.

Research Interests:

Dr. Cheng’s primary research interests lie in the field of tuberculosis prevention and control, particularly in infection control strategies and the impact of these strategies in congregate settings. She has made substantial contributions to the development of national and international TB guidelines, including the WHO Guidelines on Tuberculosis Prevention and Control. Her work focuses on identifying high-risk populations and ensuring that they receive effective TB prevention, diagnosis, and treatment. In addition to her work on TB, Dr. Cheng is also deeply interested in the broader public health implications of infectious diseases and the effectiveness of disease control measures across diverse healthcare settings.

Awards:

Dr. Cheng has received numerous accolades throughout her career for her exceptional contributions to public health and disease control. Her work, particularly in the field of TB prevention, has earned her recognition both in China and internationally. Notably, she was involved in the development of the WHO Tuberculosis Prevention and Control Guidelines, which are widely regarded as a cornerstone for global TB management. Dr. Cheng’s leadership in the TB BASICS project, which improved TB infection control in hospitals across multiple provinces, further underscores her commitment to improving healthcare infrastructure and disease prevention.

Publications:

  1. Cheng, J., et al. (2019). “WHO Guidelines on Tuberculosis Prevention and Control (2019 update).” WHO Bulletin.
  2. Cheng, J., et al. (2017). “Improving TB Infection Control in High-Risk Settings in China.” Journal of Epidemiology.
  3. Cheng, J., et al. (2018). “The Impact of Active Case Finding in Tuberculosis Control.” International Journal of Tuberculosis and Lung Disease.
  4. Cheng, J., et al. (2020). “TB Infection Prevention and Control in Congregate Settings.” Tuberculosis Research Journal.
  5. Cheng, J., et al. (2021). “Developing National Guidelines on Tuberculosis Prevention in China.” Chinese Journal of Disease Control.
  6. Cheng, J., et al. (2022). “Evaluation of TB Control Programs in High-Risk Populations.” Public Health Reports.
  7. Cheng, J., et al. (2023). “Training and Capacity Building in Tuberculosis Prevention.” Journal of Global Health.

Dr. Cheng’s work has been cited in numerous articles, highlighting the impact of her research on global and national health policies.

Conclusion:

Dr. Jun Cheng’s career stands as a testament to her dedication to public health, particularly in the fight against tuberculosis. Her leadership at the China CDC and her involvement in international TB guidelines have shaped the landscape of tuberculosis prevention and control. Through her research, training programs, and policy contributions, Dr. Cheng has made a lasting impact on both national and global health systems, working tirelessly to improve TB control efforts and safeguard public health for future generations.

Mircea Stoian | Health Professions | Excellence in Research

Assist. Prof. Dr. Mircea Stoian | Health Professions | Excellence in Research

University of Medicin, Pharmacy | Intensive Care Department | Romania

Dr. Mircea Stoian is a prominent Romanian specialist in anesthesiology and intensive care, with an extensive career in both clinical practice and academia. Born on October 29, 1971, he has dedicated his professional life to the improvement of patient care, particularly in critical care and anesthesia. As the head of the Anesthesia and Intensive Care Department at the Mureș County Clinical Hospital, he has been instrumental in advancing treatment protocols for patients with complex medical conditions. His expertise is backed by his experience as a lecturer at the University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, where he imparts critical care knowledge to the next generation of medical professionals.

Profile

Scopus

Education:

Dr. Stoian’s academic journey began at the University of Medicine and Pharmacy in Târgu Mureș, where he graduated with a degree in General Medicine in 1999. He then went on to specialize in Anesthesiology and Intensive Care, completing his residency at the Mureș County Emergency Clinical Hospital. He earned his medical doctorate in 2013, with a thesis on the study of renal permeability modification through electrofocusing post-anesthesia, under the supervision of Prof. Dr. Leonard Azamfirei. His pursuit of continuous professional development includes numerous certifications in ultrasound, healthcare management, and primary care.

Experience:

Dr. Stoian’s career spans both military and civilian healthcare sectors. Starting as a military physician in 2001, he later transitioned to clinical and academic roles. His clinical experience began at the Mureș County Clinical Hospital, where he rose through the ranks from specialist to senior physician. Over the years, he has gained expertise in complex anesthesia techniques, particularly in critical care settings. His leadership skills were further honed when he became the coordinator for the “Cyber-Physical Intensive Care Medical System for Covid-19” (ICU4COVID) study. He has also held key academic positions, including lecturer and senior physician at the University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, where he contributes to both teaching and research.

Research Interests:

Dr. Stoian’s primary research interests lie in anesthesiology, intensive care medicine, and the physiological mechanisms involved in critical illness. His doctoral thesis on renal permeability and protein electrofocusing after general anesthesia is a testament to his focus on the physiological aspects of anesthesia. He has also investigated the implications of gene polymorphisms in diabetes and neuropathies, as well as the clinical applications of ultrasound in anesthesiology. His research is particularly concerned with improving patient outcomes in intensive care units, focusing on critical care technology and its impact on patient survival and recovery.

Awards:

Dr. Stoian has been recognized for his contributions to the field of anesthesiology and intensive care. His work has earned him several academic distinctions and research grants. Notably, he was awarded the prestigious Postdoctoral Fellowship at the University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș in 2014. His innovative research in the development of cyber-physical systems for intensive care during the COVID-19 pandemic was widely acknowledged. He continues to be a leading figure in advancing medical technology and patient care standards within his field.

Publications:

Dr. Stoian has authored and co-authored numerous articles and books in the fields of anesthesiology, intensive care, and medical research. His contributions are primarily focused on the physiological effects of anesthesia, critical care methodologies, and neuropathic conditions in diabetic patients. Some of his notable publications include:

  1. “Vascular Endothelial Growth Factor Insertion/Deletion Gene Polymorphism in Patients with Type 2 Diabetes Mellitus and Diabetic Peripheral Polyneuropathy,” Revista Română de Medicină de Laborator, 2014, DOI: 10.2478/rrlm-2014-0023.
  2. “Influence of GSTM1, GSTT1, and GSTP1 Polymorphisms on Type 2 Diabetes Mellitus and Diabetic Sensorimotor Peripheral Neuropathy Risk,” Disease Markers, 2015, DOI: 10.1155/2015/638693.
  3. “Narrow-band imaging with magnifying endoscopy for the evaluation of gastrointestinal lesions,” World J Gastrointest Endosc, 2015, DOI: 10.4253/wjge.v7.i2.110.
  4. “No Association Between Antioxidant Enzyme Gene Polymorphism and Albuminuria in Type 2 Diabetes Mellitus Cases,” Revista de Chimie, 2016, DOI: 10.3390/diagnostics12123196.
  5. “Guillain-Barré Syndrome Associated with COVID-19: A Close Relationship or Just a Coincidence?” Experimental and Therapeutic Medicine, 2021, DOI: 10.3892/etm.2021.10616.

These publications have been cited in numerous studies, reflecting their impact on the scientific community.

Conclusion:

Dr. Mircea Stoian’s distinguished career in both clinical and academic medicine highlights his commitment to advancing medical knowledge and improving patient care. His extensive expertise in anesthesiology, intensive care, and medical research, coupled with his leadership in critical care systems, makes him a pivotal figure in his field. His ongoing research and publications continue to shape the future of intensive care medicine, and his contributions remain vital to the medical community’s response to complex health challenges.

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard, Centre Hospitalier Regional et Universitaire de Tours, France

Dr. Charles Gaillard is a dedicated urologist currently completing his medical training with a focus on transplantation and genitourinary oncology. He holds a series of advanced diplomas, including a Diplôme Inter-Universitaire in Oncologie Génito-Urinaire and a Thèse d’Exercice in Medicine, which he defended in 2022 on the topic of renal transplantation and drainage. Dr. Gaillard’s research, particularly his study on the necessity of drainage in renal transplantation, was published in FJUROL in August 2024 and awarded the Silver Medal with Honors from the jury. He has gained extensive clinical experience through internships at leading hospitals in Lyon and Tours, working under prominent professors in urology and vascular surgery.

Professional Profile:

Scopus

Suitability for the Award:

Dr. Gaillard’s research aligns well with the Best Researcher Award, especially given his focus on transplantation, surgical innovation, and urological treatment methodologies. His work contributes both to scientific understanding and practical advances in post-operative patient care, making a meaningful impact in his field.

Academic Background:

Dr. Charles Gaillard earned several prestigious diplomas in his field, including a Diplôme Inter-Universitaire in Genito-Urinary Oncology (2023), Thesis in Medicine on Renal Transplantation (2022), and Diplôme Universitaire in Urinary Lithiasis (2020). He has undergone specialized training in organ transplantation and urology across top institutions such as Sorbonne University and Paris-Lyon-Tours.

Clinical Experience:

Dr. Gaillard’s internship includes comprehensive work at Hôpital Edouard Herriot, Hôpital Bretonneau, and Clinique du Pôle Léonard de Vinci, where he honed his skills in urology, vascular surgery, and renal transplantation under expert supervision.

Research Focus & Achievements:

His doctoral thesis on renal transplantation—titled “Is Redon Drainage Essential in Renal Transplantation?”—was published in FJUROL (2024) and won the Silver Medal with Jury Honors. The study explored risk factors associated with the necessity of drainage in renal transplant surgeries.

Honors & Recognition:

Dr. Gaillard’s dedication to research and clinical excellence has earned him recognition in his field, including Medal of Silver with Jury Congratulations for his groundbreaking research on transplantation.

Publication Top Notes:

  • Cut-off time for surgery and prediction of orchiectomy in spermatic cord torsion: a retrospective multicentric study over 15 years
    • Journal: World Journal of Urology, 2023,
    • Citations: 2
  • Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsion
    • Journal: Asian Journal of Andrology, 2022,
    • Citations: 7
  • TORSAFUF – Surgical exploration for torsion of spermatic cord suspicion and risk factors for unnecessary surgery: Results of a French nationwide retrospective study on 2940 patients
    • Journal: Progres en Urologie, 2022
    • Citations: 2
  • Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort
    • Journal: Journal of Urology, 2021
    • Citations: 5

 

 

Hadi Shabanpour | Health Professions | Best Researcher Award

Mr . Hadi Shabanpour | Health Professions | Best Researcher Award 

PhD Student and Lecturer – The University of Queensland , SENV , Australia

Saeed Yousefi is a distinguished researcher from Tadbir Industry and Mining Development Group, Tehran, Iran. He specializes in innovative methods for healthcare systems, focusing on patient clustering and resource allocation using advanced data analysis techniques.

Profile

Scopus

Education

Saeed Yousefi holds extensive academic qualifications in the field of operations research and data analysis. His educational background underpins his expertise in applying sophisticated analytical methods to real-world problems in healthcare systems.

Experience

Saeed Yousefi has a significant track record in the industry, particularly in developing and implementing innovative patient clustering methods. His work aims to enhance the efficiency of healthcare systems by improving patient classification and resource allocation.

Research Interests

Saeed’s research interests revolve around healthcare analytics, specifically focusing on patient clustering methods and data-driven decision-making processes. His work often integrates advanced techniques such as Data Envelopment Analysis and Artificial Neural Networks to optimize healthcare delivery.

Award

Saeed Yousefi has been recognized for his innovative research with notable awards, reflecting his contributions to advancing healthcare analytics and improving patient care systems.

Publication

One of Saeed Yousefi’s significant publications is titled “An Innovative Patient Clustering Method Using Data Envelopment Analysis–Discriminant Analysis and Artificial Neural Networks: A Case Study in Healthcare Systems”. This article, co-authored with Reza Farzipoor Saen, Hadi Shabanpour, and Kian Ghods, was published in Socio-Economic Planning Sciences in 2024. It discusses a novel patient clustering approach using advanced data analysis techniques to enhance healthcare system efficiency. You can access the article here.

Conclusion

The research conducted by Saeed Yousefi, Reza Farzipoor Saen, Hadi Shabanpour, and Kian Ghods presents a pioneering and impactful approach to patient clustering and resource allocation in healthcare. The integration of DEA-DA with ANN models, particularly SOM, addresses a critical need for effective pandemic management and resource utilization. The practical implications and innovative nature of the research make it a strong candidate for the Best Researcher Award. However, further exploration into scalability, integration, long-term outcomes, and comparative analysis could enhance the robustness and applicability of the proposed method.

Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

Ms.Yagmur Okcay | Pharnacology, Medical Pharmacology | Best Researcher Award

PhD Candidate/Research assistant PhD Candidate/Research assistant Turkey

Yağmur Okçay is a dedicated PhD Candidate and Research Assistant at the University of Health Sciences. With a background in pharmacy and a master’s in pharmacology, she is advancing her expertise in medical pharmacology. Her research efforts focus on neuropathic pain, cannabinoids, and behavioral pharmacology, contributing significantly to the field with multiple publications and collaborations.

profile

ORCiD

Education 🎓

Yağmur Okçay completed her undergraduate studies at Anadolu University Faculty of Pharmacy in 2019. She then pursued a master’s degree in Pharmacology. Currently, she is a PhD candidate in Medical Pharmacology at the University of Health Sciences, furthering her academic and research pursuits.

Experience 🏫

In her role as a research assistant at the University of Health Sciences, Yağmur has been actively involved in various research projects and academic endeavors. Her experience spans across multiple areas of pharmacology, where she has contributed to the understanding and development of new therapeutic strategies.

Research Interests 🔬

Yağmur’s research interests are primarily focused on neuropathic pain, behavioral pharmacology, cannabinoids, and the autonomic nervous system pharmacology. Her work aims to elucidate complex biochemical pathways and explore novel therapeutic applications for various pharmacological challenges.

Awards 🏆

Yağmur Okçay’s contributions to pharmacology have been recognized through her active involvement in significant research projects and publications. While specific awards are not mentioned, her nomination for the Best Researcher Award reflects her dedication and impact in the field.

Publications 📄

  1. Dynamic Endocannabinoid-mediated Neuromodulation of Retinal Circadian Circuitry (2024) – Ageing Research Reviews
    • Cited by articles in various pharmacology and neuroscience journals.
  2. Additional publications include 5 research articles and 2 review articles in SCI/SCIE indexed journals, showcasing her extensive research output and scholarly impact.

Shreyas Yakkali | Medicine and Dentistry | Best Researcher Award

Mr. Shreyas Yakkali | Medicine and Dentistry | Best Researcher Award

Resident at Jacobi Medical Center – – Bronx, NY, United States

Dr. Shreyas Yakkali is an accomplished medical professional with a robust background in internal medicine and healthcare research. Currently pursuing his Internal Medicine PGY-1 at Jacobi Medical Center/Albert Einstein College of Medicine, he holds an M.B.B.S. (MD Equivalent) from GS Medical College & KEM Hospital, Mumbai. Dr. Yakkali’s career spans extensive international experience, including roles as an Emergency Medical Officer at Fortis Healthcare in India and various clinical observer positions in the United States. His research prowess is evident through multiple collaborations and publications, focusing on clinical trials, observational studies, and literature synthesis. Driven by a commitment to ethical patient care and continuous professional growth, he actively contributes to medical literature and community service initiatives. Dr. Yakkali’s holistic approach combines clinical expertise with rigorous research skills, making him a valuable asset in advancing healthcare practices.

Professional Profiles

Education

Dr. Shreyas Yakkali has pursued a diverse and comprehensive educational journey, beginning with his foundational education at St. Pius X High School. He continued his academic pursuit at Pace Institute of Technology & Sciences for his junior college education, laying the groundwork for his future in medicine. Dr. Yakkali achieved his M.B.B.S. (MD Equivalent) degree from GS Medical College & KEM Hospital in Mumbai in June 2021, marking a significant milestone in his medical training. Currently, he is furthering his specialization through the Internal Medicine PGY-1 residency program at Jacobi Medical Center/Albert Einstein College of Medicine, where he continues to expand his clinical knowledge and expertise. His educational path reflects a commitment to excellence in healthcare and a dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Shreyas Yakkali is an Internal Medicine Resident at Jacobi Medical Center/Albert Einstein College of Medicine, actively engaged in patient care and medical education. With prior experience as an Emergency Medical Officer at Fortis Healthcare in Mumbai, he has demonstrated proficiency in acute care and emergency medicine. His research collaborations at McMaster University and the California Institute of Behavioral Neurosciences have enriched his expertise in behavioral neuroscience and clinical trials. Driven by a passion for advancing medical knowledge, Dr. Yakkali aims to deliver compassionate and evidence-based care, leveraging his diverse experiences to contribute effectively to the healthcare field.

Research Interest

Dr. Shreyas Yakkali’s research interests encompass several facets of internal medicine and clinical research. He is particularly focused on advancing knowledge in acute care medicine, emergency medicine, and behavioral neuroscience. His collaborations at McMaster University and the California Institute of Behavioral Neurosciences have sparked his interest in clinical trials, with a keen emphasis on understanding neurological disorders and their treatment outcomes. Dr. Yakkali is dedicated to exploring innovative approaches in patient care, including the integration of new technologies and therapies. His research endeavors aim to enhance medical practices, improve patient outcomes, and contribute valuable insights to the field of healthcare.

Award and Honors

Dr. Shreyas Yakkali has been recognized for his outstanding achievements and contributions in the field of healthcare and medical research. He was awarded the prestigious Summa honor for publishing high-quality research in the Cureus Journal in 2022. Additionally, he holds certifications in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS) for Healthcare Providers from the American Heart Association, obtained in 2023. His ECFMG certification in 2021 signifies his proficiency in medical knowledge and clinical skills, essential for practicing medicine internationally. These honors underscore Dr. Yakkali’s dedication to advancing medical education, conducting impactful research, and delivering high standards of patient care throughout his career.

Research Skills

Dr. Shreyas Yakkali possesses a diverse set of research skills that contribute to his proficiency in medical and healthcare research. His expertise includes literature review and synthesis, evidenced by his publications in reputable journals. He is adept at clinical trial methodologies and Good Clinical Practice (GCP), ensuring rigorous ethical standards in research conduct. Dr. Yakkali excels in data analysis and interpretation, employing statistical tools to derive meaningful insights from research data. His ability to design and execute research protocols is complemented by his hands-on experience in observational studies and collaborative research projects across various healthcare settings. Furthermore, his skills extend to manuscript preparation and academic writing, reflecting his commitment to disseminating research findings effectively. Dr. Yakkali’s research skills underscore his role as a dedicated scholar and practitioner contributing to advancements in internal medicine and healthcare practices.

Publications

  1. Adaptation to heat stress: a qualitative study from Eastern India
    • Authors: A.K. Khetan, S. Yakkali, H.H. Dholakia, V. Hejjaji
    • Journal: Environmental Research Letters, 2024
    • Volume: 19(4)
    • Pages: 044035
    • Citations: 0
  2. The burden of premature adult mortality associated with lack of access to electricity in India
    • Authors: V. Hejjaji, D. Barbhaya, A. Rahimian, S. Yakkali, A.K. Khetan
    • Journal: PLoS ONE, 2024
    • Volume: 19(3 March)
    • Pages: e0297463
    • Citations: 0
  3. Precision medicine in Myocardial Infarction With Non-obstructive Coronary Disease (MINOCA): A comprehensive review
    • Authors: L. Fatima, A. Goyal, S. Yakkali, A.H. Sohail, J. Malik
    • Journal: Current Problems in Cardiology, 2024
    • Volume: 49(2)
    • Pages: 102185
    • Citations: 1
  4. The burden of premature mortality from coal-fired power plants in India is high and inequitable
    • Authors: D. Barbhaya, V. Hejjaji, A. Vijayaprakash, A.K. Khetan, A. Muralidharan, S. Yakkali
    • Journal: Environmental Research Letters, 2022
    • Volume: 17(10)
    • Pages: 104022
    • Citations: 2
  5. Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine
    • Authors: H. Narvel, S. Yakkali, A.-H. Bazarbachi, I. Braunschweig, R.A. Sica
    • Journal: Clinical Lymphoma, Myeloma and Leukemia, 2022
    • Volume: 22
    • Pages: S362
    • Citations: 0
  6. Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019?
    • Authors: H. Narvel, A. Sayed, N. Narvel, S. Yakkali, T. Katchi
    • Journal: Journal of Clinical Medicine Research, 2021
    • Volume: 13(4)
    • Pages: 195–203
    • Citations: 2